Award presented during the 2026 SCRS Global Site Solutions Summit Eagle Award Gala.
On October 17, 2026, the Society for Clinical Research Sites (SCRS), announced that Medpace has been recognized as the 2026 CRO SCRS Eagle Award recipient.
Medpace is honored to announce that we have been awarded the SCRS 2026 CRO Eagle Award, for the second year in a row. Since 2009, the SCRS Eagle Award has recognized one CRO and Sponsor each year who embody the importance of building trusted partnerships with clinical research sites to drive development forward.
This year, nearly 2,000 research sites from across the globe participated in the annual SCRS Eagle Award survey to evaluate sponsor and CRO partners who consistently demonstrate excellence across multiple operational areas based on their experience working together over the past 12 months.
Through the survey, nominees were scored across key operational categories including business development, budgeting approach, contract language, payment process, communication, efficient start-up, support for research participants from all communities, and effective use of technology. Medpace was selected as the CRO winner based on our overall performance rankings from this extensive community assessment.
“We are honored to be recognized as the 2026 SCRS Eagle Award winner,” said Gina Leisring, Sr. Vice President – Clinical Monitoring, Medpace. “Earning this distinction for a second consecutive year underscores our commitment to fostering strong, collaborative relationships with sites and reflects the trust our site partners place in us. We look forward to building on this momentum as we continue working together to accelerate the development of safe and effective therapies.”
– Gina Leisring, MPH, Sr. Vice-President, Clinical Monitoring & Phase I Unit at Medpace
Our Commitment to Building Strong Site Relationships
This recognition affirms our commitment to:
- Effective collaboration by establishing and maintaining open and responsive communication with sites.
- Operational excellence through the ability to streamline processes to reduce burden on sites.
- Patient-centered focus through ensuring trials remain accessible and meaningful for participants.
- Innovation using technology and integrated solutions to support efficiency and data quality.
Looking Ahead
We are grateful to SCRS and to the participating sites for this recognition. As we look to the future, Medpace will continue its focus on strengthening site relationships, enhancing collaboration, and working together to accelerate the development of safe and effective medical therapeutics.
About the Society for Clinical Research Sites (SCRS)
The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 12,000+ sites in 75+ countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection.